SCOPUS 정보 검색 플랫폼

Anticancer Research

Volumn 20, Issue 6 C, 2000, Pages 4745-4750

Oral polio vaccine and human cancer: A reassessment of SV40 as a contaminant based upon legal documents

(1) Kops, S P a

a NONE (United States)

Author keywords

Human cancer; Polio vaccine; SV40

Indexed keywords

ORAL POLIOMYELITIS VACCINE;

ARTICLE; CANCER IMMUNOTHERAPY; DRUG CONTAMINATION; DRUG MANUFACTURE; DRUG MONITORING; EVALUATION; LAW SUIT; LEGAL ASPECT; NONHUMAN; PRIORITY JOURNAL; SIMIAN VIRUS 40; VIRUS DETECTION;

DRUG CONTAMINATION; DRUG INDUSTRY; HUMANS; NEOPLASMS; POLIOVIRUS VACCINE, INACTIVATED; POLIOVIRUS VACCINE, ORAL; SIMIAN VIRUS 40; UNITED STATES;

EID: 0034491648 PISSN: 02507005 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (13)

References (27)

1
- 0033032327
- Asbestos, Chromosomal Deletions and Tumor Suppressor Gene Alterations in Human Malignant Mesothelioma
- (1999) J Cell Physiol , vol.180 , pp. 150-157
- Murthy, S.S.¹ Testa, J.R.²

2
- 0033585417
- Cell and molecular biology of simian virus 40: Implications for human infections and disease
- (1999) J National Cancer Inst , vol.91 , pp. 119-134
- Butel, J.¹ Lednicky, J.²

3
- 0033403288
- Simian Virus 40 and Human Tumors: It is Time to Study Mechanisms
- (1999) J Cell Biochemistry , vol.76 , pp. 189-193
- Carbone, M.¹

4
- 0033427739
- Presence of Simian Virus 40 Sequences in Malignant Mesotheliomas and Mesothelial Cell Proliferatios
- (1999) J Cell Biochemistry , vol.76 , pp. 181-188
- Shivapurkar, N.¹ Wiethege, T.² Wistuba, I.³ Salomon, E.⁴ Milchgrub, S.⁵ Muller, K.⁶ Churg, A.⁷ Pass, H.⁸ Gazdar, A.⁹

5
- 0033572314
- Antisense to SV40 early gene region induces growth arrest and apoptosis in T-Antigen - Positive human pleural mesothelioma cells
- (1999) Cancer Research , vol.59 , pp. 6068-6073
- Guo, W.¹ Welser, C.² Nguyen³ Schrump⁴

6
- 0033064918
- New molecular and epidemiological issues in mesotheliomas: Role of SV40
- (1999) J Cell Physiol , vol.180 , pp. 167-172
- Carbone, M.¹ Fisher, E.² Powers, A.³ Pass, H.I.⁴ Rizzo, P.⁵

7
- 0031609382
- Discovery of Simian Virus 40(SV40) and its Relationship to Poliomyelitis Virus Vaccines
- Basel, Karger
- (1998) Dev. Biol. Stand. , vol.94 , pp. 183-190
- Hilleman, M.R.¹

8
- 0030671131
- Simian virus 40, poliovaccines, and human tumors: A review of recent developments
- (1997) Oncogene , vol.15 , pp. 1877-1888
- Carbone, M.¹ Rizzo, P.² Pass, H.I.³

9
- 0002328996
- 6. Detection of a "non-detectable" simian virus (vacuolating agent) present in rhesus and cynomolgus monkey-kidney cell culture material. A preliminary report
- Pan American Health Organization and the World Health Organization, Washington, DC 6-7 June
- (1960) Second International Conference on Live Poliovirus Vaccines , pp. 79-85
- Sweet, B.H.¹ Hilleman, M.R.²

10
- 0006336815
- Transcript of Proceeding of Department of Health, Education and Welfare, U. S. Public Health Service, NIH, Conf. On Production and Testing Requirements for Live Poliovirus Vaccine, Thurs. and Fri., August 18 & 19, 1960, Bethesda, MD. U.S. Exhibit No. 353-354 - In Re Sabin Polio Vaccine Litigation, MDL 780, U.S.D.C., MD - Baltimore, Maryland

11
- 0006336816
- Proposed Regulations, August 1960. Plaintiff's Exhibit No. 43 - In Re Sabin Polio Vaccine Litigation, MDL 780, U.S.D.C., MD - Baltimore, Maryland

12
- 0006288969
- Federal Register, Saturday, March 25, 1961 at page 2565-2568, Sec. 73. 110, et seq

13
- 0006320966
- Memorandum from Director of N.I.H. to Surgeon General of the United States dated March 16, 1961. Defendant's Exhibit No. 33 - In Re Sabin Polio Vaccine Litigation, MDL 780, U.S.D.C., MD - Baltimore, Maryland

14
- 0006320967
- 21 Code of Federal Regulations 630.10(b)(3): "Each seed virus used in manufacture shall be demonstrated to be free of extraneous microbial agents except for unavoidable bacteriophage."

15
- 0006377001
- 21 Code of Federal Regulations, 600.3(u)

16
- 0031610314
- Product Quality Control testing for the Oral Polio Vaccine
- (1998) Developments in Biologic Standardization, Simian Virus 40 (SV40): A Possible Human Polyvirus , pp. 217-219
- Brock¹ Kelleher² Zlotnick³

17
- 0006344548
- January
- (1997) Transcript of Proceedings 300-307 of the Developments in Biological Standards

18
- 0006346368
- Recommendation of the CDC's Advisory Committee on Immunization Practices, June 17, 1999

19
- 0006289617
- Lederle internal memorandum from Dr. Biddle to Dr. Danielson dated November 8, 1961, submitted in response to discovery requests in the polio litigation

20
- 0006378640
- Letter of submission of American Cyanamid to the United States dated November 6, 1961. Defendant's Exhibit No. 57- In Re Sabin Polio Vaccine Litigation, MDL 780, U.S.D.C., MD - Baltimore, Maryland

21
- 0006290113
- Testimony of Mary Ritchey, Ph.D., Vice President of Operations, Wyeth-Lederle Vaccines and Pediatrics Business Group, dated April 14, 1998, in the U.S.D.C. for the E.D. of Ohio, Civil Action No. 94-423 and 94-425

22
- 0006305749
- Letter from John T. Conner of Merck & Co. to Dr. Leroy Burney, Surgeon General of the United States, dated 12/16/60 - Plaintiff's Exhibit No. 54 - In Re Sabin Polio Vaccine Litigation, MDL 780, U.S.D.C., MD - Baltimore, Maryland

23
- 0006382952
- Letter from Albert Sabin M.D. to Dr.I.S. Danielson, Lederle Laboratories, dated October 8, 1962 - Plaintiff's Exhibit No. 178 In Re Sabin Polio Vaccine Litigation, MDL 780, U.S.D.C., MD - Baltimore, Maryland

24
- 0006338620
- Lederle internal memorandum dated March 14, 1979 - Plaintiff's Exhibit No. 483 - In Re Sabin Polio Vaccine Litigation, MDL 780, U.S.D.C., MD - Baltimore, Maryland

25
- 0006288610
- 21 Code of Federal Regulations § 630.17(e)

26
- 0006289947
- Sworn affidavit in Stuart v. American Cyanamid Co., U.S.D.C., S.D.N.Y. 95 Civ. 4940 dated 2/5/96 by Lederle's Senior Director and Responsible Head Regulatory Affairs and Technical Assessment

27
- 0033572586
- Unique strains of SV 40 in commercial poliovaccines from 1955 not readily identifiable with current testing for SV 40 infection
- (1999) Cancer Res , vol.59 , pp. 60103-60108
- Rizzo, P.¹ DiResta, I.² Powers, A.³ Rattner, H.⁴ Carbone, M.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.